HomeGNMSF • OTCMKTS
add
Genmab
Nakaraang pagsara
$191.40
Sakop ng araw
$192.93 - $194.95
Sakop ng taon
$190.15 - $323.02
Market cap
12.81B USD
Average na Volume
5.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.54B | 17.57% |
Gastos sa pagpapatakbo | 3.15B | 6.78% |
Net na kita | 1.27B | -39.83% |
Net profit margin | 22.85 | -48.82% |
Kita sa bawat share | 0.29 | -99.12% |
EBITDA | 2.20B | 26.09% |
Aktuwal na % ng binabayarang buwis | 26.35% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 17.32B | -37.08% |
Kabuuang asset | 39.66B | 12.55% |
Kabuuang sagutin | 7.74B | 87.54% |
Kabuuang equity | 31.92B | — |
Natitirang share | 63.51M | — |
Presyo para makapag-book | 0.38 | — |
Return on assets | 13.53% | — |
Return on capital | 16.33% | — |
Cash Flow
Net change in cash
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.27B | -39.83% |
Cash mula sa mga operasyon | 2.03B | -0.20% |
Cash mula sa pag-invest | 224.00M | -77.78% |
Cash mula sa financing | -276.00M | -1,480.00% |
Net change in cash | 2.01B | -40.84% |
Malayang cash flow | 1.42B | 9.09% |
Tungkol
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Itinatag
1999
Website
Mga Empleyado
2,635
